Homepage
Medication Guide
Indications of Trientine (Curior)
Trientine (Curior) is a copper chelator, with trientine tetrahydrochloride as its main component. It is used for the treatment of adult patients with stable Wilson's disease, and is particularly s...
501
Tuesday, September 9th, 2025, 15:26
How to Use Trientine (CUVRIOR)
Trientine (CUVRIOR) is a copper chelator, with trientine tetrahydrochloride as its main component. It is used for the treatment of adult patients with Wilson's disease who have achieved copper dep...
503
Tuesday, September 9th, 2025, 13:32
Precautions for Dacomitinib
It is of great importance for both patients and doctors to understand the precautions before using dacomitinib (Vizimpro). Dacomitinib is an oral targeted therapeutic drug, commonly used in the treatm...
501
Monday, September 8th, 2025, 17:01
Dacomitinib: Clinical Uses, Recommended Dosage, Potential Side Effects
Dacomitinib is an oral tyrosine kinase inhibitor primarily used as a first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) harboring specific EGFR gene mutations. EGFR, ...
501
Monday, September 8th, 2025, 16:56
How to Buy Dacomitinib at a Lower Cost
Dacomitinib, with the English name Dacomitinib, is originally developed by Pfizer Inc. of the United States. It is a highly effective drug for the treatment of metastatic non-small cell lung cancer (N...
501
Monday, September 8th, 2025, 16:44
What is the Price of Dacomitinib?
Dacomitinib is a second-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that has demonstrated significant efficacy in the treatment of EGFR mutation-positive...
502
Monday, September 8th, 2025, 16:36
What Are the Purchase Channels for Dacomitinib?
Dacomitinib is a second-generation EGFR tyrosine kinase inhibitor, which has been approved in China for the first-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC). The drug ...
501
Monday, September 8th, 2025, 16:32
What Are the Purchasing Channels for Dacomitinib?
Dacomitinib, also known by other names such as Vizimpro, Dacoplice, is mainly used for the treatment of metastatic non-small cell lung cancer (NSCLC) with positive epidermal growth factor receptor (EG...
501
Monday, September 8th, 2025, 16:28
How to Purchase Dacomitinib
The original developer of Dacomitinib (Vizimpro) is Pfizer Inc. of the United States. It is a second-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, widely ...
502
Monday, September 8th, 2025, 16:12
What is the 2025 Latest Price of Dacomitinib?
Dacomitinib, a second-generation EGFR tyrosine kinase inhibitor developed by Pfizer, is mainly used for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. As a key drug in target...
501
Monday, September 8th, 2025, 16:05
4 / 87
865 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved